UK's NICE (National Institute for Clinical Excellence) appraisal of childhood inhalers appealed
This article was originally published in Clinica
Executive Summary
Draft guidance issued by the UK's health technology assessment body, the National Institute for Clinical Excellence (NICE), on inhaler systems for childhood asthma, has been appealed. In line with stated policy, NICE will not comment on the appraisal nor on the nature of the appeal, which was heard on August 31, until it issues its final guidance - due in mid-September at the earliest.